R Maltoni, A Roncadori, W Balzi,
M Mazza,
F Nicolini… - Biomedicines, 2024 - mdpi.com
Background: Cyclin-dependent kinase 4 and 6 (CDK4 and CDK6) inhibitors have changed
the therapeutic management of hormone receptor-positive (HR+) metastatic breast cancer …